Champions Oncology Inc CSBR:NASDAQ

Last Price$9.47NASDAQ Previous Close - Last Trade as of 3:59PM ET 8/12/22

Today's Change+0.07(0.74%)
Bid (Size)$9.43 (29)
Ask (Size)$9.50 (44)
Day Low / High$9.44 - 9.51
Volume1.3 K
 

View Biotechnology IndustryPeer Comparison as of 08/12/2022

 

Champions Oncology Inc ( NASDAQ )

Price: $9.47
Change: +0.07 (0.74%)
Volume: 1.3 K
3:59PM ET 8/12/2022
 
 

Brainstorm Cell Therapeutics Inc ( NASDAQ )

Price: $3.50
Change: +0.55 (18.64%)
Volume: 367.9 K
3:59PM ET 8/12/2022
 
 

Enzo Biochem Inc ( NYSE )

Price: $2.67
Change: -0.02 (0.74%)
Volume: 19.1 K
7:00PM ET 8/12/2022
 
 

Anixa Biosciences Inc ( NASDAQ )

Price: $4.06
Change: +0.16 (4.10%)
Volume: 67.6 K
3:59PM ET 8/12/2022
 
 

Galectin Therapeutics Inc ( NASDAQ )

Price: $2.07
Change: +0.04 (1.97%)
Volume: 57.0 K
4:00PM ET 8/12/2022
 

Read more news Recent News

-- Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Posts Q4 Loss $-0.02
4:00PM ET 7/21/2022 MT Newswires

...

Champions Oncology to Collaborate With Cyclica to Jointly Develop Small Molecule Therapeutics
11:07AM ET 5/31/2022 MT Newswires

Champions Oncology (CSBR) said Tuesday it will jointly develop small molecule therapeutics in partnership with biotech firm Cyclica. The partnership will...

Champions Oncology Fiscal Q3 EPS Declines, Revenue Increases
5:01PM ET 3/15/2022 MT Newswires

Champions Oncology (CSBR) on Tuesday reported a non-GAAP EPS of $0.07 for fiscal Q3, down from $0.09 a year earlier. Analysts polled by Capital IQ...

-- Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Posts Q3 EPS $0.07, vs. Street Est of $0.04
4:52PM ET 3/15/2022 MT Newswires

...

Company Profile

Business DescriptionChampions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ. View company web site for more details
AddressOne University Plaza
Hackensack, New Jersey 07601
Phone+1.201.808.8400
Number of Employees115
Recent SEC Filing07/22/202210-K
President, Chief Executive Officer & DirectorRonnie Morris
Chief Financial OfficerDavid Barry Miller
Executive Vice President-Scientific OperationisKarin Abarca Heidemann
Chief Commercial OfficerMichael Ritchie

Company Highlights

Price Open$9.51
Previous Close$9.40
52 Week Range$6.81 - 11.00
Market Capitalization$128.1 M
Shares Outstanding13.5 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement09/12/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings315.67
Earnings per Share$0.04
Beta vs. S&P 500N/A
Revenue$27.1 M
Net Profit Margin1.12%
Return on Equity6.46%

Analyst Ratings as of 07/29/2022

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset